IceCure Medical Ltd. (ICCM) Reports Q3 Loss, Misses Revenue Estimates
Portfolio Pulse from
IceCure Medical Ltd. (ICCM) reported a Q3 loss of $0.08 per share, missing the Zacks Consensus Estimate of a $0.07 loss.
November 26, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IceCure Medical Ltd. reported a Q3 loss of $0.08 per share, which is worse than the expected loss of $0.07 per share according to Zacks Consensus Estimate.
The reported loss per share of $0.08 is worse than the expected $0.07, indicating a negative earnings surprise. This could lead to a short-term negative impact on the stock price as investors react to the earnings miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100